Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease - 12-Month follow-up: Angiogenic gene therapy

Journal of Internal Medicine

Volumn 250, Issue 5, 2001, Pages 373-381

  Sarkar, N ^a   Ruck A ^a   Kallner G ^a   Y Hassan, S ^a   Blomberg, P ^a   Islam, K B ^a   Van Der Linden, J ^a   Lindblom, D ^a   Nygren, A T ^a   Lind, B ^a   Brodin, L A ^a   Drvota, V ^a   Sylvén, Christer ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Coronary artery disease; Gene therapy; Plasmid; Thoracotomy

Indexed keywords

BIOLOGICAL MARKER; GLYCERYL TRINITRATE; RECOMBINANT DNA; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN;

ADULT; AGED; ANGINA PECTORIS; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ACTIVITY; DRUG EFFECT; DRUG SAFETY; FEMALE; FOLLOW UP; GENE THERAPY; GENE TRANSFER; HEART FUNCTION; HEART LEFT VENTRICLE; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIA; MALE; MORTALITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFRACTORY PERIOD; SURVIVAL RATE; TERMINAL DISEASE; THORACOTOMY; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; CORONARY ARTERIOSCLEROSIS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FOLLOW-UP STUDIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; PLASMIDS; THORACOTOMY; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0034767908     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2001.00905.x     Document Type: Article

References (19)

1. Therapeutic angiogenesis
2. Molecular mechanisms of blood vessel growth
3. The fibroblast growth factor family: Structural and biological properties
4. Vascular endothelial growth factor and its receptors
5. Cardiovascular gene therapy
6. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease
7. Myocardial doppler tissue velocity improves following myocardial gene therapy with VEGF-A165 plasmid in patients with inoperable angina pectoris
8. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion
9. Changes in collateral channel filling immediatly after controlled coronary artery occlusion by an angioplasty balloon in human subjects
10. Direct myocardial transfection in two animal models
11. Behavior of genes directly injected into the rat heart in vivo
12. Catheter-based transcutaneous transendocardial myocardial gene transfer
13. Gene transfer by intramyocardial injection of plasmid DNA in rats
14. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease
15. Clinical trials in coronary angiogenesis: Issues, problems, consensus. An expert panel summary
16. Double-blind, placebo controlled trial of recombinant human vascular endothelial growth factor-The VIVA trial
17. A randomised blinded clinical trial comparing percutaneous laser myocardial revascularization (using Biosense LV mapping) vs placebo in patients with refractory coronary ischenia
18. Electromagnetic guidance for catheter-based transendocardial injection: A platform for intramyocardial angiogenesis therapy